Translate

Dental Implants - Medical Devices Pipeline Assessment, 2017

"Dental Implants - Medical Devices Pipeline Assessment, 2017" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.

Description-

Summary

GlobalData's Medical Devices sector report, Dental Implants - Medical Devices Pipeline Assessment, 2017" provides an overview of Dental Implants currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dental Implants pipeline products.


This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Scope

- Extensive coverage of the Dental Implants under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Dental Implants and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Dental Implants under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 Dental Implants Overview 9
3 Products under Development 10
3.1 Dental Implants - Pipeline Products by Stage of Development 10
3.2 Dental Implants - Pipeline Products by Segment 11
3.3 Dental Implants - Pipeline Products by Territory 12
3.4 Dental Implants - Pipeline Products by Regulatory Path 13
3.5 Dental Implants - Pipeline Products by Estimated Approval Date 14
3.6 Dental Implants - Ongoing Clinical Trials 15
4 Dental Implants - Pipeline Products under Development by Companies 16
4.1 Dental Implants Companies - Pipeline Products by Stage of Development 16
4.2 Dental Implants - Pipeline Products by Stage of Development 18
5 Dental Implants Companies and Product Overview 19
5.1 Amedica Corp Company Overview 19
5.1.1 Amedica Corp Pipeline Products & Ongoing Clinical Trials Overview 19
5.2 Boston University Company Overview 21
5.2.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 21
5.3 CAMLOG Biotechnologies AG Company Overview 23
5.3.1 CAMLOG Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 23
5.4 Coland Holdings Limited Company Overview 24
5.4.1 Coland Holdings Limited Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 Face Your Face HandelsGesmbH Company Overview 25
5.5.1 Face Your Face HandelsGesmbH Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 Grant Dental Technology Corporation Company Overview 26
5.6.1 Grant Dental Technology Corporation Pipeline Products & Ongoing Clinical Trials Overview 26
5.7 Interface Biologics, Inc. Company Overview 27
5.7.1 Interface Biologics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.8 Maxillent Ltd. Company Overview 28
5.8.1 Maxillent Ltd. Pipeline Products & Ongoing Clinical Trials Overview 28
5.9 Medtronic plc Company Overview 33
5.9.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 33
5.10 Megagen Co.,Ltd. Company Overview 34
5.10.1 Megagen Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview 34
5.11 Nano Interface Technology LLC (Inactive) Company Overview 36
5.11.1 Nano Interface Technology LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 36
5.12 Natural Dental Implants AG Company Overview 37
5.12.1 Natural Dental Implants AG Pipeline Products & Ongoing Clinical Trials Overview 37
5.13 Neodent Company Overview 39
5.13.1 Neodent Pipeline Products & Ongoing Clinical Trials Overview 39
5.14 Nobel Biocare Holding AG Company Overview 40
5.14.1 Nobel Biocare Holding AG Pipeline Products & Ongoing Clinical Trials Overview 40
5.15 Odontis Ltd (Inactive) Company Overview 41
5.15.1 Odontis Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 41
5.16 Omplant Ltd Company Overview 42
5.16.1 Omplant Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
5.17 Pharmaco-Kinesis Corp Company Overview 43
5.17.1 Pharmaco-Kinesis Corp Pipeline Products & Ongoing Clinical Trials Overview 43
5.18 Silver Bullet Therapeutics, Inc. Company Overview 44
5.18.1 Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
5.19 Sinclair Pharma PLC Company Overview 45
5.19.1 Sinclair Pharma PLC Pipeline Products & Ongoing Clinical Trials Overview 45
5.20 Straumann Holding AG Company Overview 46
5.20.1 Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview 46
5.21 Taragenyx Ltd Company Overview 50
5.21.1 Taragenyx Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
5.22 The University of Melbourne Company Overview 51
5.22.1 The University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview 51
5.23 The University of Utah Company Overview 52
5.23.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 52
5.24 Tissue Regeneration Systems, Inc. Company Overview 53
5.24.1 Tissue Regeneration Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.25 Zeev Implants Ltd Company Overview 54
5.25.1 Zeev Implants Ltd Pipeline Products & Ongoing Clinical Trials Overview 54
6 Dental Implants- Recent Developments 55
6.1 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd 55
6.2 Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results 55
6.3 Jul 27, 2017: Stryker reports second quarter 2017 results 56
6.4 Jul 19, 2017: Henry Schein Launches New Medical Website 57
6.5 Jul 11, 2017: Zimmer Biomet Announces Leadership Transition 58
6.6 Jul 11, 2017: Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results 59
6.7 Jul 11, 2017: Sinclair Pharma: Trading Update for the 6 months to 30 June 2017 59
6.8 Jul 05, 2017: Henry Schein Supports Volunteer Endodontists Expanding Oral Health Care In Jamaica 60
6.9 Jun 27, 2017: Henry Schein Settles Litigation 61
6.10 Jun 18, 2017: New Improved Design AlphaUniverse Multi Unit Abutment System 61
6.11 Jun 13, 2017: Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter Related to Its Zhejiang, China Manufacturing Facility 62
6.12 Jun 08, 2017: Amedica Releases 2016 Preliminary Earnings Report and Business Update 62
6.13 Jun 05, 2017: FDA Pushes Back UDI Compliance Deadlines for Low-Risk Medical Devices 64
6.14 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 64
6.15 May 09, 2017: Henry Schein Reports Record First Quarter Financial Results 67
6.16 Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results 69
6.17 Apr 27, 2017: Strong performance continues as Straumann posts 15% organic growth in Q1 70
6.18 Apr 25, 2017: Stryker reports first quarter 2017 results 73
6.19 Apr 19, 2017: Amedica Announces Delayed Filing of Annual Report on Form 10-K and Receipt of Nasdaq Letter 74



Comments